For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
Research To Practice | Oncology Videos · Dr. Neil Love
April 26, 20251h 33m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Ms Marianne J Davies, Dr Edward B Garon, Ms Marissa Marti-Smith and Dr Tiffany A Traina, including the following topics:
- Introduction (0:00)
- Overview of Antibody-Drug Conjugates (ADCs) (4:40)
- Trastuzumab Deruxtecan (T-DXd) in Patients with HER2-Positive Metastatic Breast Cancer (mBC) with and without Brain Metastases (12:40)
- Role of ADCs for Patients with ER-Positive mBC (35:09)
- T-DXd in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) with HER2 Alterations (52:20)
- Emerging Role of ADCs for Patients with Progressive EGFR-Mutant NSCLC (1:12:20)